Pluvicto Interactions
There are 214 drugs known to interact with Pluvicto (lutetium lu 177 vipivotide tetraxetan), along with 2 disease interactions. Of the total drug interactions, 79 are major, and 135 are moderate.
- View all 214 medications that may interact with Pluvicto
- View Pluvicto disease interactions (2)
Most frequently checked interactions
View interaction reports for Pluvicto (lutetium lu 177 vipivotide tetraxetan) and the medicines listed below.
- acetaminophen
- Acidophilus with Pectin (lactobacillus acidophilus)
- Adderall (amphetamine / dextroamphetamine)
- Advil (ibuprofen)
- albendazole
- alendronate
- alprostadil
- Ambien (zolpidem)
- amitriptyline
- amlodipine
- amoxicillin
- amoxicillin / clavulanate
- amphetamine
- apalutamide
- apixaban
- ashwaganda
- atorvastatin
- clonazepam
- clonidine
- Effexor (venlafaxine)
- levothyroxine
- losartan
- Lupron (leuprolide)
- melatonin
- ondansetron
- pravastatin
- prednisone
- quetiapine
- Zoladex (goserelin)
- Zytiga (abiraterone)
Pluvicto disease interactions
There are 2 disease interactions with Pluvicto (lutetium lu 177 vipivotide tetraxetan) which include:
Report options
QR code containing a link to this page
More about Pluvicto (lutetium lu 177 vipivotide tetraxetan)
- Pluvicto consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (3)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: therapeutic radiopharmaceuticals
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
